Inspection Record

SCA Pharmaceuticals LLC — FDA 483 Findings

US FDAInspected 2024-12-20Published 2025-01-21 7 findingsEquipment and facilityAseptic processing and sterility assuranceDocumentation and recordsProcess validationDeviation, CAPA, and investigation

Inspectors Samir C Gala · Jazmine N BrownThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

Written procedures are not for the cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing or holding of a drug product.

2Aseptic processing and sterility assurance

Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established and followed.

3Equipment and facility

Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate design to facilitate operations for its intended use and cleaning and maintenance.

4Aseptic processing and sterility assurance

Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.

5Documentation and records

Batch production and control records do not include complete information relating to the production and control of each batch.

6Process validation

Your firm failed to establish written procedures for production and process controls designed to assure that the drug products have the identity, strength, purity, and quality that they are purported or represented to possess.

7Deviation, CAPA, and investigation

There is a failure to thoroughly review any unexplained discrepancy whether or not the batch has been ah eady distributed.

About this record

Extracted automatically from the document US FDA published on 2025-01-21. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

2026-03-13 · US FDA · 3 findings2025-10-30 · US FDA · 3 findings2015-07-10 · US FDA · 7 findings2018-04-09 · US FDA · 8 findings2018-10-24 · US FDA · 10 findings2018-01-08 · US FDA · 6 findings
SCA Pharmaceuticals LLC findings history — including this company's other documents US FDA documents, 2025 Go to Findings search